A23V 2250/7058
Vitamin b9
Official title: Vitamin B9
A23V2250/7058 (Vitamin b9) appears on 6 US grants and 6 published applications in this corpus.
Search patents in A23V- Granted patents
- 6
- Published applications
- 6
- Assignees
- 3
- Inventors
- 12
- Latest grant
- 3 May 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 2 |
| 2019 | 0 | 2 |
| 2020 | 2 | 1 |
| 2021 | 1 | 0 |
| 2022 | 3 | 0 |
By publication year.
Recent patents
- Vitamin supplement compositions with enhanced bioavailability3 May 2022US 11,318,150 B1
- Multivitamin extrudates22 Mar 2022US 11,278,046 B2Dsm IP Assets B.V.
- Nutritional formulations and kits for bariatric individuals4 Jan 2022US 11,213,059 B2Mantra Pharma
- Infant formulas having vitamin complexes with enhanced bioavailability21 Sep 2021US 11,122,833 B1
- Nutritional formulations using human milk oligosaccharides for modulating inflammation21 Apr 2020US 10,624,916 B2Abbott Laboratories
- Nutritional formulations using human milk oligosaccharides for modulating inflammation23 Jul 2020US 2020/0230162 A1Abbott Laboratories
- Nutritional formulations and kits for bariatric individuals27 Jun 2019US 2019/0191754 A1Mantra Pharma
- Compositions of micronutrients and phytochemicals for optimal human health7 Mar 2019US 2019/0069585 A1
- Nutritional Product for Decreasing Phenylalanine Levels in PKU Patients25 Oct 2018US 2018/0303144 A1
- Multivitamin extrudates20 Sep 2018US 2018/0263270 A1Dsm IP Assets B.V.
Most cited
By later US patents
- Vitamin supplement compositions with enhanced bioavailability5US 10,617,700 B12020
- Nutritional formulations using human milk oligosaccharides for modulating inflammation2US 10,624,916 B2Abbott Laboratories · 2020
- Infant formulas having vitamin complexes with enhanced bioavailability2US 11,122,833 B12021
- Vitamin supplement compositions with enhanced bioavailability2US 11,318,150 B12022
- Multivitamin extrudates1US 11,278,046 B2Dsm IP Assets B.V. · 2022